source
- Sanofi plans to pursue higher European drug prices rather than delay product launches under Trump policySanofi indicated it may seek higher drug prices in Europe as part of a deal related to President Trump's pricing policies. Unlike other major European pharma companies that have warned the policie…
- Gilead places CAR-T program on partial hold after ICANS cases; Agios delays PDUFA submissionGilead announced a partial clinical hold on its CAR-T therapy after several patients experienced immune effector cell-associated neurotoxicity syndrome (ICANS). The hold will pause enrollment and…